Zinc and Metallothionein Levels and Expression of Zinc Transporters in Androgen-Independent Subline of LNCaP Cells

Journal of Andrology

Volumn 25, Issue 1, 2004, Pages 154-161

  Iguchi, Kazuhiro ^a   Otsuka, Takashi ^a   Usui, Shigeyuki ^a   Ishii, Kenichiro ^b   Onishi, Takehisa ^c   Sugimura, Yoshiki ^c   Hirano, Kazuyuki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hormone refractory; Metallothionein; ZnT1; ZnT3

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BINDING PROTEIN; METALLOTHIONEIN; METRIBOLONE; UNCLASSIFIED DRUG; ZINC; ZINC BINDING PROTEIN; ZINC TRANSPORTER 1;

ARTICLE; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; ZINC DEFICIENCY;

EID: 0346993066     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2004.tb02771.x     Document Type: Article

References (43)

1. Andrews GK. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals. 2001;14:223-237.
2. Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals. 2001;14:331-341.
3. Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD. Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci U S A. 1999;96:1716-1721.
4. Costello LC, Franklin RB. Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme. 1981;26:281-287.
5. Costello LC, Liu Y, Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997;272:28875-28881.
6. Costello LC, Liu Y, Zou J, Franklin RB. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J Biol Chem. 1999;274:17499-17504.
7. Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 1985;65:238-309.
8. Emmett JL, Green LF, Papantonious A. Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies. J Urol. 1960;83:471-484.
9. Fair WR, Couch J, Wehner N. Prostatic antibacterial factor. Urology. 1976;7:169-177.
10. Fair WR, Parrish RF. Antibacterial substances in prostatic fluid. Prog Clin Biol Res. 1981;75:247-264.
11. Gaither LA, Eide DJ. Functional expression of the human hZIP2 zinc transporter. J Biol Chem. 2000;275:5560-5564.
12. Ghatak S, Oliveria P, Kaplan P, Ho SM. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate. Prostate. 1996;29:91-100.
13. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482-487.
14. Gyorkey F, Min K, Huff JA, Gyorkey P. Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res. 1967;27:1348-1353.
15. Huang L, Gitschier J. A novel gene involved in zinc transporter is deficient in the lethal milk mouse. Nat Genet. 1997;17:292-297.
16. Huggins C, Hodges CV. Studies on prostatic cancer. I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1:293-297.
17. Iguchi K, Hamatake M, Ishida R, et al. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem. 1998;253:766-770.
18. Ishii K, Usui S, Sugimura Y, Yamamoto H, Yoshikawa K, Hirano K. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull. 2001;24:226-230.
19. Kokontis J, Takakura K, Hay N, Liao S. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res. 1994;54:1566-1573.
20. Langmade SJ, Ravindra R, Daniels PJ, Andrews GK. The transcription factor MTF-1 mediates metal regulation of the mouse ZnT1 gene. J Biol Chem. 2000;275:34803-34809.
21. Lee JY, Cole TB, Palmiter RD, Koh JY. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci. 2000;20:RC79 (1-5).
22. Liang Y, Liu Y, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999;40:200-207.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
24. Mawson CA, Fischer MI. Zinc content of the genital organs of the rat. Nature. 1951;167:859.
25. Mawson CA, Fischer MI. The occurrence of zinc in the human prostate gland. Can J Med Sci. 1952;30:336-339.
26. Mawson CA, Fischer MI. Zinc and carbonic anhydrase in human semen. Biochem J. 1953;55:696-700.
27. McMahon RJ, Cousins RJ. Regulation of the zinc transporter ZnT-1 by dietary zinc. Proc Natl Acad Sci U S A. 1998;95:4841-4846.
28. Murgia C, Vespognani I, Cerase J, Nobio N, Perozzi G. Cloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cells. Am J Physiol. 1999;277:G1231-G1239.
29. Ogunlewe JO, Osegbe DN. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer. 1989;63:1388-1392.
30. Onishi T, Yamakawa K, Franco OE, Kawamura J, Watanabe M, Shiraishi T, Kitazawa S. Mitogen-activated protein kinase pathway is involved in alpha6 integrin gene expression in androgen-independent prostate cancer cells: role of proximal Sp1 consensus sequence. Biochim Biophys Acta. 2001;1538:218-227.
31. Onishi T, Yamakawa K, Franco OE, Suzuki R, Kawamura J. p27Kip1 is the key mediator of phenylacetate induced cell cycle arrest in human prostate cancer cells. Anticancer Res. 2000;20:3075-3081.
32. Onosaka S, Tanaka K, Doi M, Okahara K. A simplified procedure for determination of metallothionein in animal tissues. Eisei Kagaku, 1978;24:128-131.
33. Pagé B, Pagé M, Noël C. A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol. 1993;3:473-476.
34. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci U S A. 1998;95:8428-8430.
35. Palmiter RD, Cole TB, Findley SD. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 1996a;15:1784-1791.
36. Palmiter RD, Cole TB, Quaife CJ, Findley SD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A. 1996b;93:14934-14939.
37. Palmiter RD, Findley SD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 1995;14:639-649.
38. Prasad AS. Zinc deficiency in human subjects. Prog Clin Biol Res. 1983;129:1-33.
39. Prasad AS. Clinical and biochemical manifestation zinc deficiency in human subjects. J Pharmacol. 1985;16:344-352.
40. Shiina H, Igawa M, Ishibe T. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression. Br J Urol. 1996a;77:96-101.
41. Shiina H, Igawa M, Ishibe T. Clinical study on estramustine binding protein (EMBP) in human prostate. Prostate. 1996b;29:169-176.
42. Tohyama C, Suzuki JS, Homma S, Karasawa M, Kuroki T, Nishimura H, Nishimura N. Testosterone-dependent induction of metallothionein in genital organs of male rats. Biochem J. 1996;317:97-102.
43. Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 α-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate. Prostate. 1996;29:1-14.